Position in GALT
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$2,013,788
-$490,419 QoQ
Shares Held
721,788
+19.9% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Wealthspire Advisors, LLC holds $11,039,371 across 15 Biotechnology names. GALT ranks #2 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,706 | $6,726,603 | |
| 2 | GALT |
Galectin Therapeutics Inc
This page
|
721,788 | $2,013,788 | |
| 3 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
34,359 | $850,728 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
895 | $399,653 | |
| 5 | MREO |
Mereo BioPharma Group plc
|
796,036 | $262,691 | |
| 6 | RNXT |
RenovoRx, Inc.
|
252,525 | $255,050 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,683 | $200,853 | |
| 8 | OLMA |
Olema Pharmaceuticals, Inc.
|
10,172 | $151,664 |
All Filings in GALT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,013,788 | 721,788 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $2,504,207 | 601,973 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,033,156 | 479,518 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,011,782 | 479,518 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $486,016 | 398,374 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $513,902 | 398,374 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,095,528 | 398,374 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $900,325 | 398,374 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $952,113 | 398,374 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $305,210 | 183,862 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $353,015 | 183,862 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $264,761 | 183,862 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $386,110 | 183,862 | Shares | Sole | 2023-05-09 | |
| 2022-09-30 | $28,288 | 17,355 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $22,735 | 17,355 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $27,941 | 17,355 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $28,679 | 13,855 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $53,757 | 13,855 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $44,336 | 13,855 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $30,065 | 13,855 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $31,035 | 13,855 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $36,992 | 13,855 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $42,396 | 13,855 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $27,155 | 13,855 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||